Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-07 Purchase |
2025-04-08 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
3,600 | $9.1 | $32,760 | 5,561,602 (Direct) |
View |
| 2025-04-04 Purchase |
2025-04-07 07:50 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
5,500 | $8.73 | $48,015 | 5,558,002 (Direct) |
View |
| 2025-01-10 Purchase |
2025-01-13 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,500 | $12.51 | $31,275 | 5,552,502 (Direct) |
View |
| 2025-01-06 Purchase |
2025-01-08 06:10 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,900 | $13.58 | $39,391 | 5,550,002 (Direct) |
View |
| 2025-01-03 Purchase |
2025-01-07 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
3,400 | $12.95 | $44,030 | 5,547,102 (Direct) |
View |
| 2025-01-02 Purchase |
2025-01-06 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,000 | $11.97 | $23,940 | 5,543,702 (Direct) |
View |
| 2024-12-31 Purchase |
2025-01-03 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,400 | $11.36 | $27,264 | 5,541,702 (Direct) |
View |
| 2024-12-30 Purchase |
2025-01-02 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
3,200 | $11.12 | $35,584 | 5,539,302 (Direct) |
View |
| 2024-11-21 Purchase |
2024-11-25 06:03 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
1,000 | $12.91 | $12,910 | 264,148 (Direct) |
View |
| 2024-09-26 Purchase |
2024-09-30 06:04 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,500 | $14.63 | $21,945 | 5,536,102 (Direct) |
View |
| 2024-08-12 Purchase |
2024-09-16 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
800 | $13.85 | $11,080 | 263,148 (Direct) |
View |
| 2024-08-06 Purchase |
2024-08-08 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,000 | $13.81 | $27,620 | 5,534,602 (Direct) |
View |
| 2024-08-05 Purchase |
2024-08-07 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
5,500 | $13.18 | $72,490 | 5,532,602 (Direct) |
View |
| 2024-08-02 Purchase |
2024-08-05 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
1,000 | $15.15 | $15,150 | 262,348 (Direct) |
View |
| 2024-07-23 Purchase |
2024-07-24 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,500 | $15.89 | $23,835 | 5,527,102 (Direct) |
View |
| 2024-07-18 Purchase |
2024-07-22 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
1,000 | $16 | $16,000 | 261,348 (Direct) |
View |
| 2024-06-13 Purchase |
2024-06-17 06:10 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
174,825 | $14.3 | $2,499,998 | 5,525,602 (Direct) |
View |
| 2024-04-01 Purchase |
2024-04-03 06:10 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
3,000 | $19.08 | $57,240 | 5,350,777 (Direct) |
View |
| 2024-03-22 Purchase |
2024-03-26 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,500 | $19.98 | $49,950 | 5,347,777 (Direct) |
View |
| 2024-03-20 Purchase |
2024-03-22 06:02 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,500 | $17.68 | $26,520 | 5,345,277 (Direct) |
View |
| 2024-03-05 Purchase(A) |
2024-03-07 09:41 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
3,500 | $12.49 | $43,715 | 5,343,777 (Direct) |
View |
| 2024-03-05 Purchase |
2024-03-07 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
30,500 | $12.49 | $380,945 | 5,343,777 (Direct) |
View |
| 2024-03-04 Purchase |
2024-03-06 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
4,100 | $13.03 | $53,423 | 5,340,277 (Direct) |
View |
| 2024-02-16 Purchase |
2024-02-21 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
10,800 | $11.16 | $120,528 | 5,336,177 (Direct) |
View |
| 2024-02-15 Purchase |
2024-02-20 06:04 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
12,700 | $11.07 | $140,589 | 5,325,377 (Direct) |
View |
| 2023-11-10 Purchase |
2023-11-14 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
5,000 | $10.17 | $50,838 | 5,312,677 (Direct) |
View |
| 2023-11-03 Purchase |
2023-11-07 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
3,500 | $9.11 | $31,885 | 5,307,677 (Direct) |
View |
| 2023-10-27 Purchase |
2023-10-31 06:16 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
500 | $8.57 | $4,285 | 260,348 (Direct) |
View |
| 2023-10-26 Purchase |
2023-10-30 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,500 | $7.97 | $19,925 | 5,304,177 (Direct) |
View |
| 2023-10-25 Purchase |
2023-10-27 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,500 | $7.91 | $19,775 | 5,301,677 (Direct) |
View |
| 2023-10-10 Purchase |
2023-10-12 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,000 | $9.07 | $9,070 | 5,299,177 (Direct) |
View |
| 2023-10-04 Purchase |
2023-10-05 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
2,000 | $8.63 | $17,260 | 5,298,177 (Direct) |
View |
| 2023-09-26 Purchase |
2023-09-28 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
600 | $8.71 | $5,226 | 259,848 (Direct) |
View |
| 2023-09-19 Purchase |
2023-09-21 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
4,000 | $8.95 | $35,800 | 5,296,177 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-24 Option Award |
2024-12-27 4:19 pm |
N/A 2034-12-24 |
Greenwich LifeSciences Inc. | GLSI | Hallock Kenneth Director |
41,349 | $0 | 82,698 (Direct) |
View |
| 2024-12-24 Option Award |
2024-12-27 4:19 pm |
N/A 2034-12-24 |
Greenwich LifeSciences Inc. | GLSI | Daugherty Frank Joseph Chief Medical Officer |
104,890 | $0 | 209,780 (Direct) |
View |
| 2024-12-24 Option Award |
2024-12-27 4:19 pm |
N/A 2034-12-24 |
Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner |
1,173,731 | $0 | 4,469,916 (Direct) |
View |
| 2024-12-24 Option Award |
2024-12-27 4:19 pm |
N/A 2034-12-24 |
Greenwich LifeSciences Inc. | GLSI | Rothe Eric Director |
41,349 | $0 | 82,698 (Direct) |
View |
| 2024-12-24 Option Award |
2024-12-27 4:19 pm |
N/A 2034-12-24 |
Greenwich LifeSciences Inc. | GLSI | McWilliams David Director |
61,984 | $0 | 123,968 (Direct) |
View |
| 2024-12-24 Option Award |
2024-12-27 4:19 pm |
N/A 2034-12-24 |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
149,818 | $0 | 299,636 (Direct) |
View |